Trials4Health 2026: Multi-country Phase III Clinical Trials

Project Requirements

• Duration: 48 months
• Strong justification for trial design, population, statistical power and sample size
• Clear strategies for recruitment, retention and assessment
• Demonstration of patient involvement and user engagement
• Ethical compliance following EU and national requirements
• Plans addressing gender balance and diversity in recruitment

Consortium Requirements

• Minimum of three partners from participating countries
• Complementary expertise across clinical research, methodology, data management and patient engagement
• No double funding across ERA4Health calls
• Compliance with national funding rules

Key Dates

• Pre-announcement: 13 October 2025
• Call opening: 6 November 2025
• Pre-proposal deadline: 27 January 2026
• Full proposal deadline (invited applicants): 17 June 2026
• Rebuttal period: 24 August to 4 September 2026
• Funding decisions: End of October 2026
• Project start: January to May 2027

How Inventya Can Help

Inventya helps clinical research teams navigate the complexities of cross-national health funding calls. Our expert support includes:

• Full eligibility and strategic fit assessment
• Structuring robust trial concepts for comparative-effectiveness studies
• Integrating RRI principles into trial design, planning and communication
• Strengthening clinical methodology, impact pathways and stakeholder involvement
• Reviewing your full proposal for clarity, consistency and alignment with evaluation criteria

With Inventya, your Trials4Health proposal becomes more competitive, more innovative and more aligned with what funders expect from high-quality European clinical research.

‍